Five patients who used Aventis Pharma Ltd.’s Arava rheumatoid arthritis drug have died of pneumonia over the past four months since the drug was launched in Japan, the pharmaceutical company said Tuesday.

Eleven other users of the drug, generically known as leflunomide, have developed interstitial pneumonia, according to the Japanese unit of the Franco-German pharmaceutical giant.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.